Abstract P3-09-02: Optimal anti-emetic choice for breast cancer patients receiving anthracycline and cyclophosphamide-based chemotherapy - A systematic review and network meta-analysis of randomized controlled trials
2022 ◽
2018 ◽
Vol 174
(1)
◽
pp. 27-37
◽
2018 ◽
Vol 14
(10)
◽
pp. 600
◽
2019 ◽
Vol 18
◽
pp. 153473541986691
◽
2013 ◽
Vol 23
(1)
◽
pp. 21-30
◽
Keyword(s):
2018 ◽
Vol 27
(1)
◽
pp. 9-21
◽